{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:55:34Z","timestamp":1773708934846,"version":"3.50.1"},"reference-count":90,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T00:00:00Z","timestamp":1640044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-031794"],"award-info":[{"award-number":["POCI-01-0145-FEDER-031794"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Melanoma is the deadliest form of skin cancer, and its incidence has alarmingly increased in the last few decades, creating a need for novel treatment approaches. Thus, we evaluated the combinatorial effect of doxorubicin (DOX) and hyperthermia on A375 and MNT-1 human melanoma cell lines. Cells were treated with DOX for 24, 48, and 72 h and their viabilities were assessed. The effect of DOX IC10 and IC20 (combined at 43 \u00b0C for 30, 60, and 120 min) on cell viability was further analyzed. Interference on cell cycle dynamics, reactive oxygen species (ROS) production, and apoptosis upon treatment (with 30 min at 43 \u00b0C and DOX at the IC20 for 48 h) were analyzed by flow cytometry. Combined treatment significantly decreased cell viability, but not in all tested conditions, suggesting that the effect depends on the drug concentration and heat treatment duration. Combined treatment also mediated a G2\/M phase arrest in both cell lines, as well as increasing ROS levels. Additionally, it induced early apoptosis in MNT-1 cells, while in A375 cells this effect was similar to the one caused by hyperthermia alone. These findings demonstrate that hyperthermia enhances DOX effect through cell cycle arrest, oxidative stress, and apoptotic cell death.<\/jats:p>","DOI":"10.3390\/ijms23010035","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T09:50:43Z","timestamp":1640080243000},"page":"35","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Hyperthermia Enhances Doxorubicin Therapeutic Efficacy against A375 and MNT-1 Melanoma Cells"],"prefix":"10.3390","volume":"23","author":[{"given":"Diana","family":"Salvador","sequence":"first","affiliation":[{"name":"Department of Biology and CESAM, University of Aveiro, 3810-193 Aveiro, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9882-4766","authenticated-orcid":false,"given":"Ver\u00f3nica","family":"Bastos","sequence":"additional","affiliation":[{"name":"Department of Biology and CESAM, University of Aveiro, 3810-193 Aveiro, Portugal"}]},{"given":"Helena","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Department of Biology and CESAM, University of Aveiro, 3810-193 Aveiro, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pop.2016.09.020","article-title":"Cancer in the Medically Underserved Population","volume":"44","author":"Olaku","year":"2017","journal-title":"Prim. Care"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s12035-014-9068-z","article-title":"Prevention of Photocarcinogenesis by Agonists of 5-HT1A and Antagonists of 5-HT2A Receptors","volume":"53","author":"Menezes","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"B\u00e9langer, F., Rajotte, V., and Drobetsky, E.A. (2014). A majority of human melanoma cell lines exhibits an S phase-specific defect in excision of UV-induced DNA photoproducts. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0085294"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-3-319-22539-5_4","article-title":"Melanoma: Clinical presentations","volume":"167","author":"Kibbi","year":"2016","journal-title":"Cancer Treat. Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Lombardo, N., Della Corte, M., Pelaia, C., Piazzetta, G., Lobello, N., Del Duca, E., Bennardo, L., and Nistic\u00f2, S.P. (2021). Primary Mucosal Melanoma Presenting with a Unilateral Nasal Obstruction of the Left Inferior Turbinate. Medicina, 57.","DOI":"10.3390\/medicina57040359"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11912-018-0675-0","article-title":"Mucosal Melanoma: A Literature Review","volume":"20","author":"Yde","year":"2018","journal-title":"Curr. Oncol. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3322\/caac.21565","article-title":"Cancer treatment and survivorship statistics, 2019","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-22539-5_1","article-title":"Heterogeneity in melanoma","volume":"167","author":"Shannan","year":"2016","journal-title":"Melanoma"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2018.11.070","article-title":"Optimization and in-vitro\/in-vivo evaluation of doxorubicin-loaded chitosan-alginate nanoparticles using a melanoma mouse model","volume":"556","author":"Yoncheva","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/08982104.2019.1580720","article-title":"Enhanced antitumor efficacy and attenuated cardiotoxicity of doxorubicin in combination with lycopene liposomes","volume":"30","author":"Zhu","year":"2020","journal-title":"J. Liposome Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijpharm.2017.06.022","article-title":"Tumor-specific delivery of doxorubicin through conjugation of pH-responsive peptide for overcoming drug resistance in cancer","volume":"528","author":"Feng","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.pcad.2006.10.002","article-title":"Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management","volume":"49","author":"Takemura","year":"2007","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.2174\/092986709788803312","article-title":"Doxorubicin: The Good, the Bad and the Ugly Effect","volume":"16","author":"Carvalho","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2217\/fon-2019-0458","article-title":"Molecular avenues in targeted doxorubicin cancer therapy","volume":"16","author":"Roychoudhury","year":"2020","journal-title":"Future Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: Molecular advances and pharmacologie developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbrc.2008.11.059","article-title":"Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs","volume":"378","author":"Ashley","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.rvsc.2014.07.008","article-title":"Murine xenograft model demonstrates significant radio-sensitising effect of liposomal doxorubicin in a combination therapy for Feline Injection Site Sarcoma","volume":"97","author":"Petznek","year":"2014","journal-title":"Res. Vet. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1634\/theoncologist.11-4-336","article-title":"Pegylated liposomal doxorubicin consolidation therapy after platinum\/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian cancer patients","volume":"11","author":"Rocconi","year":"2006","journal-title":"Oncologist"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.cbi.2014.06.013","article-title":"Induction of apoptosis by doxorubicin-transferrin conjugate compared to free doxorubicin in the human leukemia cell lines","volume":"220","author":"Szwed","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3109\/10717544.2015.1040527","article-title":"Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma","volume":"23","author":"Yuan","year":"2016","journal-title":"Drug Deliv."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1200\/JCO.2007.14.1242","article-title":"Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin\u2019s lymphoma","volume":"26","author":"Hershman","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4103\/0973-1482.139267","article-title":"An overview of doxorubicin formulations in cancer therapy","volume":"10","author":"Rivankar","year":"2014","journal-title":"J. Cancer Res. Ther."},{"key":"ref_24","first-page":"960","article-title":"Reversal of doxorubicin resistance by hydrophobic, but not hydrophilic, forskolins","volume":"40","author":"Wadler","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.biopha.2017.04.033","article-title":"Cardioprotective mechanisms of phytochemicals against doxorubicin-induced cardiotoxicity","volume":"90","author":"Abushouk","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bcp.2014.04.001","article-title":"Hydroxytyrosol ameliorates oxidative stress and mitochondrial dysfunction in doxorubicin-induced cardiotoxicity in rats with breast cancer","volume":"90","author":"Pamplona","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/02656736.2016.1213430","article-title":"A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer","volume":"32","author":"Harima","year":"2016","journal-title":"Int. J. Hyperth."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1080\/02656736.2019.1631494","article-title":"Increased uptake of doxorubicin by cells undergoing heat stress does not explain its synergistic cytotoxicity with hyperthermia","volume":"36","author":"Sharma","year":"2019","journal-title":"Int. J. Hyperth."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"9851","DOI":"10.1073\/pnas.1101053108","article-title":"Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition","volume":"108","author":"Krawczyk","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3109\/02656736.2011.608217","article-title":"Hyperthermia improves therapeutic efficacy of doxorubicin carried by mesoporous silica nanocontainers in human lung cancer cells","volume":"27","author":"Lee","year":"2011","journal-title":"Int. J. Hyperth."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13014-015-0462-0","article-title":"Effects of hyperthermia on DNA repair pathways: One treatment to inhibit them all","volume":"10","author":"Oei","year":"2015","journal-title":"Radiat. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/02656731003636436","article-title":"Tumour perfusion and associated physiology: Characterization and significance for hyperthermia","volume":"26","author":"Vaupel","year":"2010","journal-title":"Int. J. Hyperth."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Susa, M., Iyer, A.K., Ryu, K., Hornicek, F.J., Mankin, H., Amiji, M.M., and Duan, Z. (2009). Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma. BMC Cancer, 9.","DOI":"10.1186\/1471-2407-9-399"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10637-006-9002-y","article-title":"A phase II, open label, monotherapy study of liposomal doxorubicin in patients with metastatic malignant melanoma","volume":"25","author":"Smylie","year":"2007","journal-title":"Investig. New Drugs"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00008390-200304000-00015","article-title":"Phase II study of pegylated liposomal doxorubicin in patients with metastatic malignant melanoma failing standard chemotherapy treatment","volume":"13","author":"Vorobiof","year":"2003","journal-title":"Melanoma Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.nano.2015.04.001","article-title":"Intratumoral gold-doxorubicin is effective in treating melanoma in mice","volume":"11","author":"Zhang","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2217\/hep.15.41","article-title":"Mechanisms of doxorubicin resistance in hepatocellular carcinoma","volume":"3","author":"Cox","year":"2016","journal-title":"Hepat. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1039\/c1nr10580a","article-title":"Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: Performance and mechanism","volume":"3","author":"Shen","year":"2011","journal-title":"Nanoscale"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Terasaki, A., Kurokawa, H., Ito, H., Komatsu, Y., Matano, D., Terasaki, M., Bando, H., Hara, H., and Matsui, H. (2020). Elevated Production of Mitochondrial Reactive Oxygen Species via Hyperthermia Enhanced Cytotoxic Effect of Doxorubicin in Human Breast Cancer Cell Lines MDA-MB-453 and MCF-7. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249522"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.18388\/abp.2003_3726","article-title":"Hyperthermia can differentially modulate the repair of doxorubicin-damaged DNA in normal and cancer cells","volume":"50","author":"Blasiak","year":"2003","journal-title":"Acta Biochim. Pol."},{"key":"ref_41","first-page":"591","article-title":"Vital signs: Melanoma incidence and mortality trends and projections\u2014United States, 1982\u20132030","volume":"64","author":"Guy","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.nano.2014.11.006","article-title":"Recent advances in targeted nanoparticles drug delivery to melanoma","volume":"11","author":"Li","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1034\/j.1600-0749.2003.00030.x","article-title":"Melanin Inhibits Cytotoxic Effects of Doxorubicin and Daunorubicin in MOLT 4 Cells","volume":"16","author":"Svensson","year":"2003","journal-title":"Pigment Cell Res."},{"key":"ref_44","first-page":"275","article-title":"Combined cytotoxicity effect of hyperthermia and anthracycline antibiotics on human tumor cells","volume":"74","author":"Ohnoshi","year":"1985","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000129213","article-title":"Adriamycin combined with hyperthermia and dipyridamole is cytotoxic both in vitro and in vivo","volume":"24","author":"Sakaguchi","year":"1992","journal-title":"Eur. Surg. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/030089168707300204","article-title":"Interaction of heat with chemotherapy in vitro: Effect on cell viability and protein synthesis in human and murine cell lines","volume":"73","author":"Supino","year":"1987","journal-title":"Tumori J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1872-2040(19)61186-2","article-title":"New Methods for Cell Cycle Analysis","volume":"47","author":"Fang","year":"2019","journal-title":"Chin. J. Anal. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semcdb.2005.02.007","article-title":"New insights into cyclins, CDKs, and cell cycle control","volume":"16","author":"Dynlacht","year":"2005","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/pcmr.12136","article-title":"DNA repair and cell cycle checkpoint defects as drivers and therapeutic targets in melanoma","volume":"26","author":"Pavey","year":"2013","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pharmthera.2013.01.011","article-title":"Targeting cell cycle regulation in cancer therapy","volume":"138","author":"Miranda","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.phymed.2013.09.002","article-title":"Berberine in combination with doxorubicin suppresses growth of murine melanoma B16F10 cells in culture and xenograft","volume":"21","author":"Mittal","year":"2014","journal-title":"Phytomedicine"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"110375","DOI":"10.1016\/j.msec.2019.110375","article-title":"Improved delivery of doxorubicin using rationally designed PEGylated platinum nanoparticles for the treatment of melanoma","volume":"108","author":"Mukherjee","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.biopha.2018.10.183","article-title":"Adjuvant therapy with stattic enriches the anti-proliferative effect of doxorubicin in human ZR-75-1 breast cancer cells via arresting cell cycle and inducing apoptosis","volume":"109","author":"Ghorbani","year":"2019","journal-title":"Biom. Pharmacother."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1002\/cam4.2330","article-title":"Modulated electro-hyperthermia induced p53 driven apoptosis and cell cycle arrest additively support doxorubicin chemotherapy of colorectal cancer in vitro","volume":"8","author":"Vancsik","year":"2019","journal-title":"Cancer Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"BSR20210442","DOI":"10.1042\/BSR20210442","article-title":"Sublethal hyperthermia enhances anticancer activity of doxorubicin in chronically hypoxic HepG2 cells through ROS-dependent mechanism","volume":"41","author":"Wang","year":"2021","journal-title":"Biosci. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/stem.5530070606","article-title":"Antitumor activity of hyperthermia alone or in combination with cisplatin and melphalan in primary cultures of human malignant melanoma","volume":"7","author":"Zaffaroni","year":"1989","journal-title":"Int. J. Cell Cloning"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/02656739509022491","article-title":"Hyperthermia and platinum complexes: Time between treatments and synergy in vitro and in vivo","volume":"11","author":"Kusumoto","year":"1995","journal-title":"Int. J. Hyperth."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.canlet.2016.03.042","article-title":"Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals","volume":"387","author":"Prasad","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2467940","DOI":"10.1155\/2017\/2467940","article-title":"The Roles of ROS in Cancer Heterogeneity and Therapy","volume":"2017","author":"Porcacchia","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-3163-5-14","article-title":"Reactive oxygen species: Role in the development of cancer and various chronic conditions","volume":"5","author":"Waris","year":"2006","journal-title":"J. Carcinogen."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1021\/acs.jmedchem.6b01243","article-title":"Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria","volume":"60","author":"Dharmaraja","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","article-title":"ROS in cancer therapy: The bright side of the moon","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Hou, C.-H., Lin, F.-L., Hou, S.-M., and Liu, J.-F. (2014). Hyperthermia Induces Apoptosis through Endoplasmic Reticulum and Reactive Oxygen Species in Human Osteosarcoma Cells. Int. J. Mol. Sci., 15.","DOI":"10.3390\/ijms151017380"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.arr.2012.10.004","article-title":"Oxidative stress and cancer: An overview","volume":"12","author":"Sosa","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1521020","DOI":"10.1155\/2017\/1521020","article-title":"Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity","volume":"2017","author":"Cappetta","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3892\/ijo.2016.3558","article-title":"Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines","volume":"49","author":"Calaf","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_68","first-page":"258","article-title":"Salubrinal Enhances Doxorubicin Sensitivity in Human Cholangiocarcinoma Cells Through Promoting DNA Damage","volume":"33","author":"Yu","year":"2018","journal-title":"Cancer Biother. Radiopharm."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0378-4274(01)00329-0","article-title":"Doxorubicin-induced persistent oxidative stress to cardiac myocytes","volume":"121","author":"Zhou","year":"2001","journal-title":"Toxicol. Lett."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1152\/ajpregu.00299.2019","article-title":"Doxorubicin-induced oxidative stress differentially regulates proteolytic signaling in cardiac and skeletal muscle","volume":"318","author":"Montalvo","year":"2020","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Asensio-L\u00f3pez, M.C., Soler, F., Pascual-Figal, D., Fern\u00e1ndez-Belda, F., and Lax, A. (2017). Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0172803"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/emm.2006.63","article-title":"Doxorubicin-induced reactive oxygen species generation and intracellular Ca2+increase are reciprocally modulated in rat cardiomyocytes","volume":"38","author":"Kim","year":"2006","journal-title":"Exp. Mol. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.freeradbiomed.2011.11.019","article-title":"Investigating the role of melanin in UVA\/UVB- and hydrogen peroxide-induced cellular and mitochondrial ROS production and mitochondrial DNA damage in human melanoma cells","volume":"52","author":"Swalwell","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: A radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ijc.1378","article-title":"Drug-resistance in human melanoma","volume":"93","author":"Helmbach","year":"2001","journal-title":"Int. J. Cancer"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1751-1097.2008.00309.x","article-title":"Melanosomal Damage in Normal Human Melanocytes Induced by UVB and Metal Uptake-A Basis for the Pro-oxidant State of Melanoma","volume":"84","author":"Gidanian","year":"2009","journal-title":"Photochem. Photobiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R","article-title":"Annexin V-affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure","volume":"31","author":"Nieland","year":"1998","journal-title":"Cytometry"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.21873\/anticanres.13347","article-title":"Hyperthermia Suppresses Post\u2014In Vitro Proliferation and Tumor Growth in Murine Malignant Melanoma and Colon Carcinoma","volume":"39","author":"Mantso","year":"2019","journal-title":"Anticancer Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/sj.jid.5701114","article-title":"Hyperthermia Induces Endoplasmic Reticulum-Mediated Apoptosis in Melanoma and Non-Melanoma Skin Cancer Cells","volume":"128","author":"Shellman","year":"2008","journal-title":"J. Investig. Dermatol."},{"key":"ref_80","first-page":"2694","article-title":"The prednisolone phosphate-induced suppression of the angiogenic function of tumor-associated macrophages enhances the antitumor effects of doxorubicin on B16.F10 murine melanoma cells in vitro","volume":"42","author":"Licarete","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s11095-007-9366-5","article-title":"Combination Therapy of Heparin\u2013Deoxycholic Acid Conjugate and Doxorubicin against Squamous Cell Carcinoma and B16F10 Melanoma","volume":"25","author":"Park","year":"2008","journal-title":"Pharm. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00000658-198412000-00016","article-title":"A prospective randomized study of regional extremity perfusion in patients with malignant melanoma","volume":"200","author":"Ghussen","year":"1984","journal-title":"Ann. Surg."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF01556581","article-title":"Eleven years\u2019 experience with hyperthermic perfusion for melanoma of the extremities","volume":"3","author":"Stehlin","year":"1979","journal-title":"World J. Surg."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1200\/JCO.1996.14.2.479","article-title":"Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: Results of a tumor necrosis factor dose-escalation study","volume":"14","author":"Fraker","year":"1996","journal-title":"J. Clinic. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/bmj.4.5946.679","article-title":"Clinical effects of whole-body hyperthermia in advanced malignancy","volume":"4","author":"Pettigrew","year":"1974","journal-title":"Br. Med. J."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"20150207","DOI":"10.1259\/bjr.20150207","article-title":"Applications of nanoparticles for diagnosis and therapy of cancer","volume":"88","author":"Baetke","year":"2015","journal-title":"Br. J. Radiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2147\/IJN.S28344","article-title":"Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model","volume":"7","author":"Basel","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.1021\/nn100870z","article-title":"Attenuation of mouse melanoma by A\/C magnetic field after delivery of bi-magnetic nanoparticles by neural progenitor cells","volume":"4","author":"Rachakatla","year":"2010","journal-title":"ACS Nano"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13550-021-00868-6","article-title":"Magnetic nanoparticles in theranostics of malignant melanoma","volume":"11","author":"Shevtsov","year":"2021","journal-title":"EJNMMI Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.2147\/IJN.S261638","article-title":"Preparation and Evaluation of Doxorubicin-Loaded PLA-PEG-FA Copolymer Containing Superparamagnetic Iron Oxide Nanoparticles (SPIONs) for Cancer Treatment: Combination Therapy with Hyperthermia and Chemotherapy","volume":"15","author":"Khaledian","year":"2020","journal-title":"Int. J. Nanomed."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/1\/35\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:50:35Z","timestamp":1760169035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/1\/35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,21]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["ijms23010035"],"URL":"https:\/\/doi.org\/10.3390\/ijms23010035","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,21]]}}}